Early versus late response to daratumumab-based triplet therapies in patients with multiple myeloma: a pooled analysis of trials POLLUX, CASTOR and MAIA

Citation:

Wang J, Arroyo-Suarez R, Dasari S, et al. Leuk Lymphoma. 2022 Jul;63(7):1669-1677. Epub 2022 Feb 10. PMID: 35142582.